![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
01 1000420 (1)
02 1000437 (1)
03 1000441 (1)
04 1000452 (1)
05 1000485 (1)
06 1000496 (1)
07 1000500 (1)
01 Abacavir Related Compound A (20 mg) ([4-(2,6-diamino-9H-purin-9-yl)cyclopent-2-enyl]methanol) (1)
02 Abacavir Related Compound B (20 mg) ([4-(2,5-diamino-6-chloropyrimidin-4-ylamino)cyclopent-2-enyl]methanol) (1)
03 Abacavir Related Compound C (20 mg) ([(1S,4R)-4-(2-amino-6-chloro-9H-purin-9-yl)cyclopent-2-enyl]methanol hydrochloride) (1)
04 Abacavir Related Compound D (20 mg) (N6-Cyclopropyl-9-{(1R,4S)-4-[(2,5-diamino-6-chlorpyrimidin-4-yloxy)methyl] cyclopent-2-enyl}-9H-purine-2,6-diamine) (1)
05 Abacavir Related Compounds Mixture (15 mg) (1)
06 Abacavir Stereoisomers Mixture (15 mg) (1)
07 Abacavir System Suitability Mixture (15 mg) (A mixture containing abacavir sulfate and trans-abacavir) (1)
01 124752-25-6 (1)
02 172015-79-1 (1)
03 N/A (5)